Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 21, 2014; 20(27): 8898-8909
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.8898
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.8898
Type | Agents | Mechanism of action | Most common adverse events |
Bulking agents | Psyllium | Increase in stool bulk and reduction in consistency by luminal water binding | Bloating |
Methylcellulose | Flatulence | ||
Calcium polycarbophil | |||
Stool softeners | Docusate potassium | Softening and lubrication of stools by increasing water secretion | Nausea |
(surfactants) | Docusate sodium | Vomiting | |
Docusate calcium | Abdominal pain/cramps | ||
Rectal urgency | |||
Osmotic laxatives | Milk of Magnesia (magnesium hydroxide) | Osmotic water retention, decreased stool consistency, and increase fecal volume and peristalsis | Sweet taste |
Magnesium citrate | Nausea | ||
Magnesium sulphate | Bloating | ||
Sodium picosulphate/magnesium citrate (Picoprep®) | Flatulence | ||
Lactulose/lactilol | Abdominal pain/cramps | ||
Sorbitol | Electrolyte disturbances (?) | ||
Polyethylene glycol (macrogol) | |||
Stimulant laxatives | Anthraquinones | Luminal water retention through activation of CAMP, and induction of colonic contractions by acting on enteric nerves | Abdominal pain/cramps |
Senna | Dehydration | ||
Cascara | Electrolyte disturbances | ||
Bisacodyl | Muscle cramps | ||
Phenolphthalein | Melanosis coli/colonic inertia (?) |
- Citation: Jadallah KA, Kullab SM, Sanders DS. Constipation-predominant irritable bowel syndrome: A review of current and emerging drug therapies. World J Gastroenterol 2014; 20(27): 8898-8909
- URL: https://www.wjgnet.com/1007-9327/full/v20/i27/8898.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i27.8898